Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP412241.RA_RKxfFdeB4kuvPUxpSLFH8g4pLG7Vv_9nxzSxqJKgmk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP412241.RA_RKxfFdeB4kuvPUxpSLFH8g4pLG7Vv_9nxzSxqJKgmk130_assertion type Assertion NP412241.RA_RKxfFdeB4kuvPUxpSLFH8g4pLG7Vv_9nxzSxqJKgmk130_head.
- NP412241.RA_RKxfFdeB4kuvPUxpSLFH8g4pLG7Vv_9nxzSxqJKgmk130_assertion description "[Similar to other factors implicated in kidney cancer, FLCN has been shown to modulate activation of mammalian target of rapamycin (mTOR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412241.RA_RKxfFdeB4kuvPUxpSLFH8g4pLG7Vv_9nxzSxqJKgmk130_provenance.
- NP412241.RA_RKxfFdeB4kuvPUxpSLFH8g4pLG7Vv_9nxzSxqJKgmk130_assertion evidence source_evidence_literature NP412241.RA_RKxfFdeB4kuvPUxpSLFH8g4pLG7Vv_9nxzSxqJKgmk130_provenance.
- NP412241.RA_RKxfFdeB4kuvPUxpSLFH8g4pLG7Vv_9nxzSxqJKgmk130_assertion SIO_000772 22709692 NP412241.RA_RKxfFdeB4kuvPUxpSLFH8g4pLG7Vv_9nxzSxqJKgmk130_provenance.
- NP412241.RA_RKxfFdeB4kuvPUxpSLFH8g4pLG7Vv_9nxzSxqJKgmk130_assertion wasDerivedFrom befree-20150227 NP412241.RA_RKxfFdeB4kuvPUxpSLFH8g4pLG7Vv_9nxzSxqJKgmk130_provenance.
- NP412241.RA_RKxfFdeB4kuvPUxpSLFH8g4pLG7Vv_9nxzSxqJKgmk130_assertion wasGeneratedBy ECO_0000203 NP412241.RA_RKxfFdeB4kuvPUxpSLFH8g4pLG7Vv_9nxzSxqJKgmk130_provenance.